OxyContin maker gets patent for drug to take care of opioid dependancy
12 September 2018, 08:14 | Silvia Roy
Richard Sackler, Who Co-Owns Oxycontin-Maker Purdue Pharma, Gets Patent for New Buprenorphine That Would Treat Opioid Addiction
The Sacklers - whose name graces wings of the Metropolitan Museum of Art and the Guggenheim - opened the second firm just four months after Purdue plead guilty to misleading doctors over how easily patients can get hooked on OxyContin in 2007, former employees told the paper.
"Thus, if opioids are taken by healthy human issues with a drug-seeking behaviour they'll lead to psychological moreover to physical dependence."Purdue Pharma is the subject of many proceedings for allegedly fueling the opioid epidemic". In addition, Colorado's attorney general is now suing Purdue Pharma for its apparent role in boosting the opioid crisis, sources say.
In 2016, there were more than 63,000 drug overdose deaths in the United States, and more than 66 percent of them were attributed to opioids, according to the most recent data from the Centers for Disease Control and Prevention.
A member of the family that owns Purdue Pharma - which is being sued by more than 1,000 jurisdictions for its alleged role in seeding the opioid crisis with its pain medication OxyContin - has been awarded a patent for a treatment for opioid use disorder. Then earlier this year, the Wall Street Journal reported that Purdue planned to stop promoting the drug. The Washington Post highlights a statement by Luke Nasta, director of NY addiction treatment center Camelot. "While our opioid medicines account for less than 2% of total prescriptions, we will continue to work collaboratively with the state toward bringing meaningful solutions to address this public health challenge". He adds that Sackler's family "shouldn't be allowed to peddle any more synthetic opiates-and that includes opioid substitutes". The drug is an altered form of buprenorphine, better known as Suboxone, which is a mild form of an opiate drug that helps curb cravings and can be offered as a temporary substitute for people addicted to heroin or other opioid drugs.
Purdue Pharma's formulation is reportedly a new version of a methadone-alternative, Suboxone, owned by the British pharmaceutical company Indivior. And it's not the first time that the company has sought a part in opioid addiction treatment endeavors, says Fortune.
Heidi Klum Reveals She Ghosted Drake After He Texted Her
As interesting as that all is, the juicier information came when Klum was asked about her dating life. "I'm embarrassed about it. DeGeneres is happy for Klum, but she was also curious if Drake ever reached out to her after the episode aired in February.
Apple expected to unveil bigger, pricier iPhone
Apple launched iPad Pro to compete with the likes of Surface and Samsung Tab but hasn't been able to grab a good market share. Likewise, if you own an Apple TV you can also tune in by using the Apple events app which comes pre-installed on the device.
McQuaid traded to New York Rangers
The six-foot-four, 212-pound defenceman has recorded 13 goals and 53 assists for 66 points with 652 penalty minutes in 462 games. This is a return to the Bruins for the 29-year-old Kampfer, who made his National Hockey League debut with the team in 2010.
England suffers blow with Luke Shaw stretchered off
Manchester United star Luke Shaw had to be taken off during England's match against Spain . " Luke Shaw remained at St. George's Park on Sunday for further rest and monitoring having sustained concussion against Spain yesterday".
Trump Associates Push Back on Woodward Book
Kelly is quoted calling Trump "an idiot", and Mattis is quoted saying Trump has the understanding of "a fifth- or sixth-grader". The book has created a controversy as Donald Trump and his office have criticised the book for misquoting the U.S. president.